• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

市售磷酸钙骨替代物的体外庆大霉素释放:载体类型对释放曲线持续时间的影响

In vitro gentamicin release from commercially available calcium-phosphate bone substitutes influence of carrier type on duration of the release profile.

作者信息

Stallmann Hein P, Faber Chris, Bronckers Antonius L J J, Nieuw Amerongen Arie V, Wuisman Paul I J M

机构信息

Orthopaedic Surgery, VU Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands.

出版信息

BMC Musculoskelet Disord. 2006 Feb 26;7:18. doi: 10.1186/1471-2474-7-18.

DOI:10.1186/1471-2474-7-18
PMID:16504140
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1459860/
Abstract

BACKGROUND

Polymethyl-methacrylate (PMMA) beads releasing antibiotics are used extensively to treat osteomyelitis, but require surgical removal afterwards because they do not degrade.

METHODS

As an alternative option, this report compares the in vitro gentamicin release profile from clinically used, biodegradable carrier-materials: six injectable cements and six granule-types. Cement cylinders and coated granules containing 3% gentamicin were submerged in dH2O and placed in a 48-sample parallel drug-release system. At regular intervals (30, 90, 180 min. and then every 24 h, for 21 days), the release fluid was exchanged and the gentamicin concentration was measured. The activity of released gentamicin was tested on Staphylococcus aureus.

RESULTS

All combinations showed initial burst-release of active gentamicin, two cements had continuous-release (17 days). The relative release of all cements (36-85%) and granules (30-62%) was higher than previously reported for injectable PMMA-cements (up to 17%) and comparable to other biodegradable carriers. From the cements residual gentamicin could be extracted, whereas the granules released all gentamicin that had adhered to the surface.

CONCLUSION

The high release achieved shows great promise for clinical application of these biodegradable drug-carriers. Using the appropriate combination, the required release profile (burst or sustained) may be achieved.

摘要

背景

释放抗生素的聚甲基丙烯酸甲酯(PMMA)珠广泛用于治疗骨髓炎,但由于它们不会降解,之后需要手术取出。

方法

作为一种替代选择,本报告比较了临床使用的可生物降解载体材料(六种可注射骨水泥和六种颗粒类型)的庆大霉素体外释放情况。将含有3%庆大霉素的骨水泥圆柱体和包衣颗粒浸入去离子水中,并置于48个样品的平行药物释放系统中。每隔一定时间(30、90、180分钟,然后每24小时,共21天)更换释放液并测量庆大霉素浓度。对释放的庆大霉素在金黄色葡萄球菌上的活性进行测试。

结果

所有组合均显示出活性庆大霉素的初始突释,两种骨水泥具有持续释放(17天)。所有骨水泥(36 - 85%)和颗粒(30 - 62%)的相对释放率高于先前报道的可注射PMMA骨水泥(高达17%),与其他可生物降解载体相当。从骨水泥中可提取出残留的庆大霉素,而颗粒释放出所有附着在表面的庆大霉素。

结论

所实现的高释放率显示出这些可生物降解药物载体在临床应用中具有巨大潜力。通过适当组合,可实现所需的释放模式(突释或持续释放)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7659/1459860/5dfcb58b7040/1471-2474-7-18-9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7659/1459860/fb752985c30a/1471-2474-7-18-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7659/1459860/05d24d4d60cd/1471-2474-7-18-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7659/1459860/6544925f06b2/1471-2474-7-18-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7659/1459860/e4cae06d1c8b/1471-2474-7-18-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7659/1459860/f4128fba71cc/1471-2474-7-18-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7659/1459860/ff6aaf10a770/1471-2474-7-18-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7659/1459860/9acd2e987a49/1471-2474-7-18-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7659/1459860/e6825b45b9b6/1471-2474-7-18-8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7659/1459860/5dfcb58b7040/1471-2474-7-18-9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7659/1459860/fb752985c30a/1471-2474-7-18-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7659/1459860/05d24d4d60cd/1471-2474-7-18-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7659/1459860/6544925f06b2/1471-2474-7-18-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7659/1459860/e4cae06d1c8b/1471-2474-7-18-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7659/1459860/f4128fba71cc/1471-2474-7-18-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7659/1459860/ff6aaf10a770/1471-2474-7-18-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7659/1459860/9acd2e987a49/1471-2474-7-18-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7659/1459860/e6825b45b9b6/1471-2474-7-18-8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7659/1459860/5dfcb58b7040/1471-2474-7-18-9.jpg

相似文献

1
In vitro gentamicin release from commercially available calcium-phosphate bone substitutes influence of carrier type on duration of the release profile.市售磷酸钙骨替代物的体外庆大霉素释放:载体类型对释放曲线持续时间的影响
BMC Musculoskelet Disord. 2006 Feb 26;7:18. doi: 10.1186/1471-2474-7-18.
2
[Elution kinetics and antimicrobial effects of gentamicin- and clindamycin-loaded bone cements in vitro].庆大霉素和克林霉素负载骨水泥的体外洗脱动力学及抗菌效果
Z Orthop Unfall. 2008 Jan-Feb;146(1):92-8. doi: 10.1055/s-2007-989301.
3
Gentamicin release from two-solution and powder-liquid poly(methyl methacrylate)-based bone cements by using novel pH method.通过新型pH法从双溶液型和粉液型聚甲基丙烯酸甲酯基骨水泥中释放庆大霉素。
J Biomed Mater Res A. 2004 Jun 1;69(3):577-83. doi: 10.1002/jbm.a.30033.
4
Continuous-release or burst-release of the antimicrobial peptide human lactoferrin 1-11 (hLF1-11) from calcium phosphate bone substitutes.抗菌肽人乳铁蛋白1-11(hLF1-11)从磷酸钙骨替代物中的持续释放或突释。
J Antimicrob Chemother. 2003 Nov;52(5):853-5. doi: 10.1093/jac/dkg443. Epub 2003 Sep 30.
5
Ready-to-use injectable calcium phosphate bone cement paste as drug carrier.可即用型注射型磷酸钙骨水泥糊剂作为药物载体。
Acta Biomater. 2013 Dec;9(12):9558-67. doi: 10.1016/j.actbio.2013.08.009. Epub 2013 Aug 14.
6
The effect of mixing on gentamicin release from polymethylmethacrylate bone cements.混合对庆大霉素从聚甲基丙烯酸甲酯骨水泥中释放的影响。
Acta Orthop Scand. 2003 Dec;74(6):670-6. doi: 10.1080/00016470310018180.
7
Gentamicin release from polymethylmethacrylate bone cements and Staphylococcus aureus biofilm formation.庆大霉素从聚甲基丙烯酸甲酯骨水泥中的释放及金黄色葡萄球菌生物膜的形成。
Acta Orthop Scand. 2000 Dec;71(6):625-9. doi: 10.1080/000164700317362280.
8
Gentamicin extended release from an injectable polymeric implant.庆大霉素从可注射聚合物植入物中的缓释。
J Control Release. 2007 Jan 22;117(1):90-6. doi: 10.1016/j.jconrel.2006.10.010. Epub 2006 Oct 11.
9
In vitro measurement of the time-related efficacy of gentamicin sulfate release from bone cements.硫酸庆大霉素从骨水泥中释放的时间相关疗效的体外测量。
Chemotherapy. 2004 Dec;50(6):302-7. doi: 10.1159/000082630. Epub 2004 Dec 8.
10
In vitro inhibition of coagulase-negative staphylococci by vancomycin/aminoglycoside-loaded cement spacers.万古霉素/氨基糖苷类负载骨水泥间隔物对凝固酶阴性葡萄球菌的体外抑制作用
Infection. 2006 Apr;34(2):81-6. doi: 10.1007/s15010-006-5039-2.

引用本文的文献

1
Calcium Phosphate Cements as Carriers of Functional Substances for the Treatment of Bone Tissue.磷酸钙骨水泥作为用于治疗骨组织的功能物质载体
Materials (Basel). 2023 May 27;16(11):4017. doi: 10.3390/ma16114017.
2
Medicated Hydroxyapatite/Collagen Hybrid Scaffolds for Bone Regeneration and Local Antimicrobial Therapy to Prevent Bone Infections.用于骨再生和局部抗菌治疗以预防骨感染的含药羟基磷灰石/胶原蛋白混合支架
Pharmaceutics. 2021 Jul 16;13(7):1090. doi: 10.3390/pharmaceutics13071090.
3
Intraoperative loading of calcium phosphate-coated implants with gentamicin prevents experimental Staphylococcus aureus infection in vivo.

本文引用的文献

1
The effect of the antimicrobial peptide, Dhvar-5, on gentamicin release from a polymethyl methacrylate bone cement.抗菌肽Dhvar-5对庆大霉素从聚甲基丙烯酸甲酯骨水泥中释放的影响。
Biomaterials. 2005 Oct;26(28):5717-26. doi: 10.1016/j.biomaterials.2005.01.036. Epub 2005 Apr 19.
2
Osteomyelitis prevention in rabbits using antimicrobial peptide hLF1-11- or gentamicin-containing calcium phosphate cement.使用含抗菌肽hLF1-11或庆大霉素的磷酸钙骨水泥预防兔骨髓炎
J Antimicrob Chemother. 2004 Aug;54(2):472-6. doi: 10.1093/jac/dkh346. Epub 2004 Jul 1.
3
Continuous-release or burst-release of the antimicrobial peptide human lactoferrin 1-11 (hLF1-11) from calcium phosphate bone substitutes.
在体负载庆大霉素涂层植入物可预防实验性金黄色葡萄球菌感染。
PLoS One. 2019 Feb 1;14(2):e0210402. doi: 10.1371/journal.pone.0210402. eCollection 2019.
4
Silica-gentamicin nanohybrids: combating antibiotic resistance, bacterial biofilms, and in vivo toxicity.硅-庆大霉素纳米杂化物:对抗抗生素耐药性、细菌生物膜和体内毒性。
Int J Nanomedicine. 2018 Nov 28;13:7939-7957. doi: 10.2147/IJN.S182611. eCollection 2018.
5
Epidemiology, microbiology and therapeutic consequences of chronic osteomyelitis in northern China: A retrospective analysis of 255 Patients.中国北方慢性骨髓炎的流行病学、微生物学和治疗后果:255 例患者的回顾性分析。
Sci Rep. 2018 Oct 5;8(1):14895. doi: 10.1038/s41598-018-33106-6.
6
Effects of silica-gentamicin nanohybrids on osteogenic differentiation of human osteoblast-like SaOS-2 cells.二氧化硅-庆大霉素纳米杂化物对人成骨样SaOS-2细胞成骨分化的影响
Int J Nanomedicine. 2018 Feb 9;13:877-893. doi: 10.2147/IJN.S147849. eCollection 2018.
7
Elution kinetics of vancomycin and gentamicin from carriers and their effects on mesenchymal stem cell proliferation: an in vitro study.万古霉素和庆大霉素从载体上的洗脱动力学及其对间充质干细胞增殖的影响:一项体外研究。
BMC Musculoskelet Disord. 2017 Sep 2;18(1):381. doi: 10.1186/s12891-017-1737-4.
8
Treatment of Staphylococcus aureus-induced chronic osteomyelitis with bone-like hydroxyapatite/poly amino acid loaded with rifapentine microspheres.利福喷丁微球负载的类骨羟基磷灰石/聚氨基酸治疗金黄色葡萄球菌诱导的慢性骨髓炎
Drug Des Devel Ther. 2015 Jul 20;9:3665-76. doi: 10.2147/DDDT.S84486. eCollection 2015.
9
A new type of biphasic calcium phosphate cement as a gentamicin carrier for osteomyelitis.一种新型双相磷酸钙骨水泥作为载药骨水泥治疗骨髓炎。
Evid Based Complement Alternat Med. 2013;2013:801374. doi: 10.1155/2013/801374. Epub 2013 Apr 9.
10
Fabrication and characterization of a rapid prototyped tissue engineering scaffold with embedded multicomponent matrix for controlled drug release.快速成型组织工程支架的构建及特性研究,该支架具有嵌入式多组分基质,用于控制药物释放。
Int J Nanomedicine. 2012;7:4285-97. doi: 10.2147/IJN.S33083. Epub 2012 Aug 3.
抗菌肽人乳铁蛋白1-11(hLF1-11)从磷酸钙骨替代物中的持续释放或突释。
J Antimicrob Chemother. 2003 Nov;52(5):853-5. doi: 10.1093/jac/dkg443. Epub 2003 Sep 30.
4
MECHANISM OF SUSTAINED-ACTION MEDICATION. THEORETICAL ANALYSIS OF RATE OF RELEASE OF SOLID DRUGS DISPERSED IN SOLID MATRICES.缓释药物的作用机制。分散于固体基质中的固体药物释放速率的理论分析。
J Pharm Sci. 1963 Dec;52:1145-9. doi: 10.1002/jps.2600521210.
5
A clinical staging system for adult osteomyelitis.成人骨髓炎的临床分期系统。
Clin Orthop Relat Res. 2003 Sep(414):7-24. doi: 10.1097/01.blo.0000088564.81746.62.
6
Release of antimicrobial peptide Dhvar-5 from polymethylmethacrylate beads.抗菌肽Dhvar-5从聚甲基丙烯酸甲酯珠粒中的释放。
J Antimicrob Chemother. 2003 Jun;51(6):1359-64. doi: 10.1093/jac/dkg258. Epub 2003 Apr 25.
7
The release of gentamicin from acrylic bone cements in a simulated prosthesis-related interfacial gap.庆大霉素在模拟假体相关界面间隙的丙烯酸骨水泥中的释放情况。
J Biomed Mater Res B Appl Biomater. 2003 Jan 15;64(1):1-5. doi: 10.1002/jbm.b.10391.
8
In vitro-in vivo characterization of gentamicin bone implants.庆大霉素骨植入物的体外-体内特性研究
J Control Release. 2002 Oct 30;83(3):353-64. doi: 10.1016/s0168-3659(02)00179-7.
9
The effect of sampling method on the elution of tobramycin from calcium sulfate.采样方法对硫酸钙中妥布霉素洗脱的影响。
Clin Orthop Relat Res. 2002 Oct(403):54-7. doi: 10.1097/00003086-200210000-00010.
10
Antimicrobial release kinetics from polymethylmethacrylate in a novel continuous flow chamber.新型连续流动腔室中聚甲基丙烯酸甲酯的抗菌剂释放动力学
Clin Orthop Relat Res. 2002 Oct(403):49-53. doi: 10.1097/00003086-200210000-00009.